Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010
- PMID: 24665132
- DOI: 10.1136/bjophthalmol-2013-304033
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010
Abstract
Background: To assess prevalence and causes of blindness and vision impairment in high-income regions and in Central/Eastern Europe in 1990 and 2010.
Methods: Based on a systematic review of medical literature, prevalence of moderate and severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60 in the better eye) and blindness (presenting visual acuity <3/60) was estimated for 1990 and 2010.
Results: Age-standardised prevalence of blindness and MSVI decreased from 0.2% to 0.1% (3.314 million to 2.736 million people) and from 1.6% to 1.0% (25.362 million to 22.176 million), respectively. Women were generally more affected than men. Cataract was the most frequent cause of blindness in all subregions in 1990, but macular degeneration and uncorrected refractive error became the most frequent causes of blindness in 2010 in all high-income countries, except for Eastern/Central Europe, where cataract remained the leading cause. Glaucoma and diabetic retinopathy were fourth and fifth most common causes for blindness for all regions at both times. Uncorrected refractive error, followed by cataract, macular degeneration, glaucoma and diabetic retinopathy, was the most common cause for MSVI in 1990 and 2010.
Conclusions: In highly developed countries, prevalence of blindness and MSVI has been reduced by 50% and 38%, respectively, and the number of blind people and people with MSVI decreased by 17.4% and 12.6%, respectively, even with the increasing number of older people in the population. In high-income countries, macular degeneration has become the most important cause of blindness, but uncorrected refractive errors continue to be the leading cause of MSVI.
Keywords: Epidemiology; Glaucoma; Public health.
Similar articles
-
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11. Lancet Glob Health. 2017. PMID: 29032195
-
Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010.Br J Ophthalmol. 2014 May;98(5):605-11. doi: 10.1136/bjophthalmol-2013-304068. Epub 2014 Mar 3. Br J Ophthalmol. 2014. PMID: 24590555
-
Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010.Br J Ophthalmol. 2014 May;98(5):612-8. doi: 10.1136/bjophthalmol-2013-304081. Epub 2014 Feb 25. Br J Ophthalmol. 2014. PMID: 24568870
-
Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010.Ophthalmology. 2013 Dec;120(12):2377-2384. doi: 10.1016/j.ophtha.2013.05.025. Epub 2013 Jul 10. Ophthalmology. 2013. PMID: 23850093
-
Prevalence and causes of vision loss in Latin America and the Caribbean: 1990-2010.Br J Ophthalmol. 2014 May;98(5):619-28. doi: 10.1136/bjophthalmol-2013-304013. Epub 2014 Feb 11. Br J Ophthalmol. 2014. PMID: 24518073
Cited by
-
Patient Perspectives in Geographic Atrophy (GA): Exploratory Qualitative Research to Understand the Impact of GA for Patients and Their Families.Br Ir Orthopt J. 2019 Nov 12;15(1):133-141. doi: 10.22599/bioj.137. Br Ir Orthopt J. 2019. PMID: 32999984 Free PMC article.
-
Stem Cell Therapy for Treatment of Ocular Disorders.Stem Cells Int. 2016;2016:8304879. doi: 10.1155/2016/8304879. Epub 2016 May 15. Stem Cells Int. 2016. PMID: 27293447 Free PMC article. Review.
-
Trabeculectomy offers better intraocular pressure reduction in intrapatient comparison to transscleral cyclophotocoagulation.Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2481-2487. doi: 10.1007/s00417-019-04450-8. Epub 2019 Sep 4. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31485731
-
Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System.Curr Eye Res. 2022 Jul;47(7):1034-1042. doi: 10.1080/02713683.2022.2053166. Epub 2022 Mar 28. Curr Eye Res. 2022. PMID: 35343355 Free PMC article.
-
Better visual outcome at 1 year with antivascular endothelial growth factor treatment according to treat-and-extend compared with pro re nata in eyes with neovascular age-related macular degeneration.Acta Ophthalmol. 2019 Aug;97(5):519-524. doi: 10.1111/aos.13989. Epub 2018 Dec 3. Acta Ophthalmol. 2019. PMID: 30511374 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical